Glass-Coated Catheter Inserts Protect against Nosocomial Infection
|
By HospiMedica International staff writers Posted on 23 Oct 2019 |

Image: Aston researcher preparing a ZnO laced glass rod (Photo courtesy of Aston University).
A phosphate glass compound containing small amounts of zinc oxide (ZnO) can help eradicate the urinary tract infections (UTIs) that plague catheter patients, according to a new study.
To develop the new catheter coating, researchers at Aston University (Birmingham, United Kingdom) heated phosphate-based glass rods (P2O5)50(Na2O)20(CaO)30 in a furnace to over 1,000°C, before slowly cooling them down to room temperature. The rods were then separated into small discs and placed into contact with bacteria in petri dishes. The rods were laced with ZnO in various concentrations order to determine the antimicrobial effects of increasing ionic degradation. They found that while 1 and 3 mol% ZnO decreased glass degradation, a higher dissolution rate was observed for 5 and 10 mol%.
They found that the higher the ZnO concentration, the larger the effect against microorganisms known to cause hospital-acquired infections (HAIs). When in direct contact, the ZnO-doped glasses showed a complete kill within 24 hours against Escherichia coli, and a significant kill rate of methicillin-resistant Staphylococcus aureus (MRSA), with complete kill achieved after 48 hours. Cytotoxic studies showed no toxic effects on the viability of uroepithelial cells. The study was published in the October 2019 issue of Materials Science & Engineering C.
“Zinc oxide coated phosphate glass, inserted into catheters, has to potential to eradicate the most common bacteria in catheter-associated UTI, E.coli and Staphylococcus aureus,” said senior author Richard Martin, PhD, of the School of Engineering and Applied Science. “This is great news for patients requiring catheters, who would be at a much-reduced risk of contracting a potentially life-threatening UTI during a hospital stay. It is also good for healthcare systems, which could save millions in the costs associated with these infections.”
A UTI is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter inserted into the bladder through the urethra to drain urine, which are indicated in between 15-25% of hospitalized patients. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.
Related Links:
Aston University
To develop the new catheter coating, researchers at Aston University (Birmingham, United Kingdom) heated phosphate-based glass rods (P2O5)50(Na2O)20(CaO)30 in a furnace to over 1,000°C, before slowly cooling them down to room temperature. The rods were then separated into small discs and placed into contact with bacteria in petri dishes. The rods were laced with ZnO in various concentrations order to determine the antimicrobial effects of increasing ionic degradation. They found that while 1 and 3 mol% ZnO decreased glass degradation, a higher dissolution rate was observed for 5 and 10 mol%.
They found that the higher the ZnO concentration, the larger the effect against microorganisms known to cause hospital-acquired infections (HAIs). When in direct contact, the ZnO-doped glasses showed a complete kill within 24 hours against Escherichia coli, and a significant kill rate of methicillin-resistant Staphylococcus aureus (MRSA), with complete kill achieved after 48 hours. Cytotoxic studies showed no toxic effects on the viability of uroepithelial cells. The study was published in the October 2019 issue of Materials Science & Engineering C.
“Zinc oxide coated phosphate glass, inserted into catheters, has to potential to eradicate the most common bacteria in catheter-associated UTI, E.coli and Staphylococcus aureus,” said senior author Richard Martin, PhD, of the School of Engineering and Applied Science. “This is great news for patients requiring catheters, who would be at a much-reduced risk of contracting a potentially life-threatening UTI during a hospital stay. It is also good for healthcare systems, which could save millions in the costs associated with these infections.”
A UTI is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter inserted into the bladder through the urethra to drain urine, which are indicated in between 15-25% of hospitalized patients. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.
Related Links:
Aston University
Latest Critical Care News
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
- New Therapeutic Approach Marks Breakthrough in Pediatric Heart Disease
- AI Model Accurately Identifies Prediabetics Using Only ECG Data
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







